FoxO1, the transcriptional chief of staff of energy metabolism

被引:188
作者
Kousteni, Stavroula [1 ]
机构
[1] Columbia Univ, Dept Med, Div Endocrinol, Coll Phys & Surg, New York, NY 10032 USA
关键词
FoxO1; Glucose metabolism; Energy homeostasis; Skeleton; Pancreas; Muscle; Liver; Adipose tissue; Osteoblasts; REGULATES ADIPOCYTE DIFFERENTIATION; SKELETAL-MUSCLE ATROPHY; BETA-CELL FUNCTION; SERUM OSTEOCALCIN; INSULIN SENSITIVITY; LIPID-METABOLISM; ENDOCRINE REGULATION; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; GENE-EXPRESSION;
D O I
10.1016/j.bone.2011.06.034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FoxO1, one of the four FoxO isoforms of Forkhead transcription factors, is highly expressed in insulin-responsive tissues, including pancreas, liver, skeletal muscle and adipose tissue, as well as in the skeleton. In all these tissues FoxO1 orchestrates the transcriptional cascades regulating glucose metabolism. Indeed, FoxO1 is a major target of insulin which inhibits its transcriptional activity via nuclear exclusion. In the pancreas, FoxO1 regulates beta-cell formation and function by a balanced dual mode of action that suppresses beta-cell proliferation but promotes survival. Hepatic glucose production is promoted and lipid metabolism is regulated by FoxO1 such that under insulin resistance they lead to hyperglycemia and dyslipidemia, two features of type 2 diabetes. In skeletal muscle FoxO1 maintains energy homeostasis during fasting and provides energy supply through breakdown of carbohydrates, a process that leads to atrophy and underlies glycemic control in insulin resistance. In a dual function, FoxO1 regulates energy and nutrient homeostasis through energy storage in white adipose tissue, but promotes energy expenditure in brown adipose tissue. In its most recently discovered novel role, FoxO1 acts as a transcriptional link between the skeleton and pancreas as well as other insulin target tissues to regulate energy homeostasis. Through its expression in osteoblasts it controls glucose metabolism, insulin sensitivity and energy expenditure. In a feedback mode of regulation, FoxO1 is also a target of insulin signaling in osteoblasts. Insulin suppresses activity of osteoblastic FoxO1 thus promoting beneficial effects of osteoblasts on glucose metabolism. The multiple actions of FoxO1 in all glucose-regulating organs, along with clinical studies suggesting that its glycemic properties are conserved in humans, establish this transcription factor as a master regulator of energy metabolism across species. This article is part of a Special Issue entitled: Interactions Between Bone, Adipose Tissue and Metabolism. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:437 / 443
页数:7
相关论文
共 77 条
[1]   TARGETED INACTIVATION OF THE INSULIN-RECEPTOR GENE IN MOUSE 3T3-L1 FIBROBLASTS VIA HOMOLOGOUS RECOMBINATION [J].
ACCILI, D ;
TAYLOR, SI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4708-4712
[2]   β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes [J].
Ahlgren, U ;
Jonsson, J ;
Jonsson, L ;
Simu, K ;
Edlund, H .
GENES & DEVELOPMENT, 1998, 12 (12) :1763-1768
[3]   Overexpression of FoxO1 Causes Proliferation of Cultured Pancreatic β Cells Exposed to Low Nutrition [J].
Ai, Jianzhong ;
Duan, Jingjing ;
Lv, Xiaoyan ;
Chen, Mianzhi ;
Yang, Qiutan ;
Sun, Huan ;
Li, Qingwei ;
Xiao, Yan ;
Wang, Yidong ;
Zhang, Zheng ;
Tan, Ruizhi ;
Liu, Yuhang ;
Zhao, Danhua ;
Chen, Tielin ;
Yang, Yang ;
Wei, Yuquan ;
Zhou, Qin .
BIOCHEMISTRY, 2010, 49 (01) :218-225
[4]   Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas [J].
Al-Masri, M. ;
Krishnamurthy, M. ;
Li, J. ;
Fellows, G. F. ;
Dong, H. H. ;
Goodyer, C. G. ;
Wang, R. .
DIABETOLOGIA, 2010, 53 (04) :699-711
[5]   Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors [J].
Allen, David L. ;
Unterman, Terry G. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 292 (01) :C188-C199
[6]   Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice [J].
Altomonte, J ;
Richter, A ;
Harbaran, S ;
Suriawinata, J ;
Nakae, J ;
Thung, SN ;
Meseck, M ;
Accili, D ;
Dong, HJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (04) :E718-E728
[7]   Foxo1 mediates insulin action on apoC-III and triglyceride metabolism [J].
Altomonte, J ;
Cong, L ;
Harbaran, S ;
Richter, A ;
Xu, J ;
Meseck, M ;
Dong, HJH .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (10) :1493-1503
[8]   FOXO animal models reveal a variety of diverse roles for FOXO transcription factors [J].
Arden, K. C. .
ONCOGENE, 2008, 27 (16) :2345-2350
[9]   FOXO1 represses peroxisome proliferator-activated receptor-γ1 and -γ2 gene promoters in primary adipocytes -: A novel paradigm to increase insulin sensitivity [J].
Armoni, Michal ;
Harel, Chava ;
Karni, Shiri ;
Chen, Hui ;
Bar-Yoseph, Fabiana ;
Ver, Marel R. ;
Quon, Michael J. ;
Karnieli, Eddy .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (29) :19881-19891
[10]   Relationship between serum osteocalcin and glycaemic variability in Type 2 diabetes [J].
Bao, Yu-Qian ;
Zhou, Mi ;
Zhou, Jian ;
Lu, Wei ;
Gao, Yun-Chao ;
Pan, Xiao-Ping ;
Tang, Jun-Ling ;
Lu, Hui-Juan ;
Jia, Wei-Ping .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (01) :50-54